| Bioactivity | Flezurafenibum (Flezurafenib) is a rapidly accelerated fibrosarcoma (Raf) kinase inhibitor, with antineoplastic effect[1]. |
| CAS | 2760321-00-2 |
| Formula | C26H21FN4O3 |
| Molar Mass | 456.47 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Flezurafenibum (Flezurafenib). WHO Drug Information, Vol. 37, No. 4, 2023. |
Flezurafenibum
CAS: 2760321-00-2 F: C26H21FN4O3 W: 456.47
Flezurafenibum (Flezurafenib) is a rapidly accelerated fibrosarcoma (Raf) kinase inhibitor, with antineoplastic effect.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.